Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01661699 · ClinicalTrials.gov registry record
Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 24
- Enrollment target
NCT01661699 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 24 participants.
The verdict
NCT01661699 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to check blood and urine levels to further define markers/tests in the blood and urine that would be useful in following patients with obstructive sleep apnea and then to see if by wearing CPAP every night, these markers can be reduced. This research is being done because currently there are no effective blood or urine markers to determine how well CPAP is working.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01661699
The ClinicalTrials.gov registry entry for NCT01661699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01661699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01661699 about?
NCT01661699 is a clinical study titled "Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance". The purpose of this study is to check blood and urine levels to further define markers/tests in the blood and urine that would be useful in following patients with obstructive sleep apnea and then to see if by wearing CPAP every night, these markers can be reduced. This research is being done becaus...
What is the current status of trial NCT01661699?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2011-08. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT01661699?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.